Sun Pharmaceutical Industries, an international, integrated, speciality pharmaceutical company, witnessed a rise in share price on Friday after the drugmaker's US-based subsidiary Taro Pharma reported strong earnings.

Taro Pharmaceuticals on Thursday reported a 9% jump in sales at USD 265 million, while its EBITDA margins jumped 18 per cent to USD 185 million compared with USD 157 million during the same period last year.

However, Taro Pharma's net profit declined 25% to USD 115 million on the back of forex loss of USD 47 million.

Shares of Sun Pharmaceutical Industries are trading at Rs 817.00, up Rs 36.95, or 4.74% at the Bombay Stock Exchange (BSE) on Friday at 12:59 p.m.

The scrip has touched an intra-day high of Rs 821.25 and low of Rs 792.00. The total volume of shares traded at the BSE is 178,334.